Special purpose of the project:
Studying the effect of Intravenous magnesium sulfate In comparison with Venous Sufentanil, about the duration block of spinal anesthesia and postoperative pain, in the Patients with shin fracture.
This project will be done in double –blind randomized controlled trial method. 70 Patients in the age group of 18 to 58 years, ASA I,II, that refer to the health centers in an elective way, for the leg surgery, are randomly divided into two groups; 1. Recipient of sufentanil intravenous solution. 2. Recipient of intravenous magnesium sulfate solution. exclusion criteria: Spinal absolute and relative contraindications; High ICP; Coagulopathy; Peripheral neuropathy of the lower extremities; Using calcium channel blockers.
After embedding peripheral venous cannula 10cc/kg ringer Crystalloid fluid, is infused to the patient. All the patients were going through the spinal anesthesia, With 10mg of the 0.5% Bupivacaine with the needle no.25 and selecting the L4-L5 space and they will undergo a surgery after being sure about the Neuraxial block and lack of understanding the sharpness of the needle in the T10 dermatome. in the group which receives sufentanil, 0.1 kg/h/µ of this Substance should be diluted in 1liter of ringer and after an hour, after ensuring about the completion of Sensory and motor block, Infusion will be done. In the second group, 8 mg/kg/h of the 10% Intravenous magnesium sulfate, should be diluted in one liter of the ringer serum, after an hour, after the ensuring about the completion of Sensory and motor block, Infusion will be done.